Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hoshi, S.
Right arrow Articles by Asano, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoshi, S.
Right arrow Articles by Asano, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 6, No. 7, pp. 1081-1090,July 1994
© 1994 Japanese Society for Immunology

Prevention of TCR-mediated apoptosis by the elevation ofcAMP

Sumio Hoshi1,3, Makoto Furutani-Selki1, Masao Seto2, Tomio Tada1 and Yoshihiro Asano1,

1 Department of Immunology, Faculty of Medicine, University of Tokyo Tokyo 113, Japan.
2 Laboratory of Chemotherapy, Aichi Cancer Center Research Institute Nagoya 464, Japan

Correspondence to: Correspondence to: Y. Asano

The stimulation through TCR-CD3 complexes by Immobilized anti-CD3 antibody induced the production of IL-2 and activation-induced cell death (ACD) in the majority of T cell hybridomas. However, some hybridomas produced IL-2 without showing any signs of ACD by the same stimulation, indicating that TCR - CD3-medlated signaling pathways of IL-2 production and of ACD are different. These pathways were discriminated from each other by protein kinase inhibitors and cAMP-elevating reagents such as forskolin. The pathway of IL-2 production but not of ACD was Inhibited by protein Mnase inhibitors. On the other hand, various cAMP-elevating reagents prevented the T cell hybridomas from TCR-mediated ACD with minimal inhibition of IL-2 production. The elevated cytoplasmic cAMP did not block dexamethasone-induced apoptosis. This indicates that apoptosis is regulated by multiple pathways. Furthermore, the inhibitory effect of cAMP is specific for the TCR-mediated signaling pathway of ACD. Messenger RNA for bci-2 was detected after treatment with forskolin.

Keywords: activation-induced cell death, apoptosis, cAMP, bci-2, forskolin


3Present address: Nippon Institute for Biological Science, 2221-1, Shinmachi, Ome, Tokyo 198, Japan

Received 1 November 1993, accepted 11 April 1994.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Tse, B. A. Marroquin, D. R. Dorscheid, and S. R. White
{beta}-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L393 - L404.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Andre, D. Couton, J. Gaston, L. Erraji, L. Renia, P. Varlet, P. Briand, and J.-G. Guillet
beta 2-Adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice
Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G647 - G654.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y.-J. Geng, Y. Ishikawa, D. E. Vatner, T. E. Wagner, S. P. Bishop, S. F. Vatner, and C. J. Homcy
Apoptosis of Cardiac Myocytes in Gs{alpha} Transgenic Mice
Circ. Res., January 22, 1999; 84(1): 34 - 42.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. Rehen, M. Varella, F. Freitas, M. Moraes, and R Linden
Contrasting effects of protein synthesis inhibition and of cyclic AMP on apoptosis in the developing retina
Development, January 5, 1996; 122(5): 1439 - 1448.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.